Gastric transposition for pharyngolaryngo-oesophageal cancer: the Unicamp experience

dc.creatorMartins, AS
dc.date2000
dc.dateSEP
dc.date2014-12-02T16:27:44Z
dc.date2015-11-26T16:02:23Z
dc.date2014-12-02T16:27:44Z
dc.date2015-11-26T16:02:23Z
dc.date.accessioned2018-03-28T22:51:49Z
dc.date.available2018-03-28T22:51:49Z
dc.identifierJournal Of Laryngology And Otology. Headley Brothers Ltd, v. 114, n. 9, n. 682, n. 689, 2000.
dc.identifier0022-2151
dc.identifierWOS:000089918700006
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/67808
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/67808
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/67808
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1265053
dc.descriptionCarcinomas of the pharyngo-oesophageal junction continue to be a challenge to head and neck surgeons. We report a series of 30 patients who underwent gastric transposition for advanced pharyngo-oesophageal tumours, with personal insights about the surgical technique and the need for neck and mediastinal node dissection. The median hospital stay was 21.6 days, with resumption of oral feedings around the 16th day in 91.7 per cent of the surgical survivors. Ten patients had multiple primary tumours (33.3 per cent), with 20 per cent of synchronous carcinomas. Serious local and systemic complications occurred in 17 patients (56.7 per cent), the most important being tracheal complications, cervical and systemic infections, fistulas, rupture of major vessels and pulmonary embolus. Post-operative deaths occurred in 20 per cent of the patients. The locoregional control of disease was significant (only 14.2 per cent of deaths from regional recurrence) but 64.2 per cent of the patients died from distant metastasis. Survival without disease was 13.3 per cent at five years. Gastric transposition was judged to be the procedure of choice for palliation or occasional cure in patients with pharyngo-oesophageal tumours.
dc.descriptiono TEXTO COMPLETO DESTE ARTIGO, ESTARÁ DISPONÍVEL À PARTIR DE AGOSTO DE 2015.
dc.description114
dc.description9
dc.description682
dc.description689
dc.languageen
dc.publisherHeadley Brothers Ltd
dc.publisherAshford
dc.publisherInglaterra
dc.relationJournal Of Laryngology And Otology
dc.relationJ. Laryngol. Otol.
dc.rightsembargo
dc.sourceWeb of Science
dc.subjecthypopharynx
dc.subjectoesophagus
dc.subjectneck
dc.subjectoesophageal neoplasms
dc.subjectpharyngeal neoplasms
dc.subjectesophagectomy
dc.subjectpharyngectomy
dc.subjectstomach, surgery
dc.subjectLymph-node Dissection
dc.subjectCervical Esophagus
dc.subjectHypopharyngeal Cancer
dc.subjectCarcinoma
dc.subjectEsophagectomy
dc.subjectReconstruction
dc.subjectAnastomosis
dc.subjectManagement
dc.subjectResection
dc.subjectSurgery
dc.titleGastric transposition for pharyngolaryngo-oesophageal cancer: the Unicamp experience
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución